Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Organigram Global Inc OGI


Primary Symbol: T.OGI

Healthcare Cannabis Cannabis
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.


TSX:OGI - Post by User

Organigram Global Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(969)
•••
  • 1hot-techwomanX
Comment by 1hot-techwomanon Jun 20, 2025 10:32am
48 Views
Post# 36616361

RE:Current Book Value from TD Bank stands at $2.82 CDN for OGI

RE:Current Book Value from TD Bank stands at $2.82 CDN for OGI
1hot-techwoman wrote:
Market Cap
$254.4M
Revenue (TTM)
$194.1M
Shares Outstanding
133.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.86
EPS
.06
Book Value
$2.82


New CEO incoming soon :) $$$

In an interview Beena ( Current CEO ) stated that up coming 3 and 4th Q are always there strongest !!!

Hang in there :)



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities